Leeper Harold M. (Mountain View CA) Michaels Alan S. (Atherton CA)
출원인 / 주소
Alza Corporation (Palo Alto CA 02)
인용정보
피인용 횟수 :
39인용 특허 :
0
초록▼
A polymeric wall adapted to release drug at a controlled rate for a prolonged period of time from a reservoir comprising a drug and a carrier which is permeable to the drug and saturated therewith during said prolonged period of time, to a body environment or a drug receptor site, the wall comprisin
A polymeric wall adapted to release drug at a controlled rate for a prolonged period of time from a reservoir comprising a drug and a carrier which is permeable to the drug and saturated therewith during said prolonged period of time, to a body environment or a drug receptor site, the wall comprising a mixture of a polymer which is biologically compatible with said environment or site and maintains its integrity while in contact therewith, has a glass transition temperature between ambient temperature and 150°C, a crystallinity of 5% to 95%, or is rubbery, and is permeable to the drug but at a rate less than that of the carrier and as a minor constituent a polymeric additive such as a polyester prepared from a glycol and a dibasic acid, polyethylene glycol, chlorinated polyethylene or copolymers of ethylene and vinyl esters or vinyl esters or vinyl halides, the amount of additive being sufficient to make the permeability of the wall to the drug substantially different than the permeability of the polymer to the drug but still less than the permeability of the carrier to the drug.
대표청구항▼
In a drug delivery device for continuously administering a drug at a controlled rate for a prolonged period of time to a body site, said device comprising a reservoir containing said drug and a carrier permeable to said drug, the amount of said drug being sufficient to maintain saturation within sai
In a drug delivery device for continuously administering a drug at a controlled rate for a prolonged period of time to a body site, said device comprising a reservoir containing said drug and a carrier permeable to said drug, the amount of said drug being sufficient to maintain saturation within said carrier during said prolonged period, and a wall surrounding said reservoir which is permeable to the drug but at a rate less than that of the carrier, whereby the drug is released from the reservoir by diffusion through the wall in which the drug dissolves in the material forming the wall and moves therethrough in the direction of lower chemical potential, the improvement comprising forming the wall from a composition comprising a mixture of: A. a polymer which is rubbery with a glass transition temperature below about 20°C, or is glassy having a glass transition temperature between about 20°C and about 150°C, or has a crystallinity between about 5% and about 95%; and B. a polymeric additive which is essentially insoluble in body fluids, is nonvolatile and nonleachable and nonextractable from the polymer under the use conditions of the composition and is selected from the group consisting of: a. essentially linear olefinically saturated polyesters having a number average molecular weight of about 500 to about 8,000 of a diol of 2 to about 7 carbon atoms or polyethylene glycol and a dibasic carboxylic acid of about 6 to about 15 carbon atoms in which the terminating group is a carboxyacyl group of about 2 to about 18 carbon atoms or an alkoxy group of about 3 to about 15 carbon atoms; b. polyethylene glycols of about 200 to about 1,500 molecular weight; c. ethylene-vinyl acetate copolymers of about 20% to about 40% by weight vinyl acetate and about 20,000 to about 30,000 number average molecular weight; d. chlorinated polyethylene of about 25% to 45% by weight chlorine and about 20,000 to about 30,000 number average molecular weight; e. ethylene-ethylacrylate copolymers of about 20% to about 40% by weight ethylacrylate and About 20,000 to about 30,000 number average molecular weight; and f. ethylene-vinyl chloride copolymers of about 25% to about 45% by weight chlorine and about 20,000 to about 30,000 number average molecular weight, the amount of additive in the mixture being sufficient to make the permeability of the composition of the drug substantially different than the permeability of the polymer to drug but less than the permeability of the carrier to drug, said composition being biologically compatible with the site, essentially non-erodible, essentially insoluble in body fluids, and, if the drug is highly water soluble, substantially impermeable to water to essentially prevent dilution of the drug by absorption of body fluids into the reservoir.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허를 인용한 특허 (39)
Peterson Laurence I. (Doylestown PA), Anesthetic delivery system.
Massara, Julio Eduardo; Massara, Nestor Gerardo; Dvoskin, Victor Oscar, Intravaginal devices containing progesterone for estrus synchronization and related proceses.
Massara, Julio Eduardo; Massara, Nestor Gerardo; Dvoskin, Victor Oscar, Intravaginal devices containing progesterone for estrus synchronization and related processes.
Greelis John Patrick ; Sirivong Mikxay ; Matsuura David G. ; Scott W. Tate ; Zupkas Paul F., Method and apparatus for placement and activation of a medical device within a body cavity.
Matsuura David G. ; Gillespie Walter Dean ; Greelis John Patrick ; Parsons Charles Lowell ; Sirivong Mikxay ; Zupkas Paul F., Method for delivering a medication.
Goldberg, David A.; Howson, David C.; Metzger, Steven W.; Buttry, Daniel A.; Saavedra, Steven Scott, Sensitive and rapid determination of antimicrobial susceptibility.
Goldberg, David A.; Howson, David C.; Metzger, Steven W.; Buttry, Daniel A.; Saavedra, Steven Scott, Sensitive and rapid determination of antimicrobial susceptibility.
Belykh Sergei I. (Moscow SUX) Davydov Anatoly B. (Moscow SUX) Moschensky Anatoly D. (Malakhovka SUX) Kanshin Nikolai N. (Moscow SUX) Kovalenko Igor L. (Moscow SUX) Kirillov Jury B. (Ryazan SUX) Osipo, Sutural material.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.